| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-03-17 |
4 |
D |
$36.00 |
$708,084 |
D/D |
(19,669) |
808,094 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-03-17 |
4 |
OE |
$34.98 |
$434,307 |
D/D |
12,385 |
827,763 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-04-17 |
4 |
OE |
$4.75 |
$95,000 |
D/D |
20,000 |
851,543 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-04-17 |
4 |
D |
$34.94 |
$345,242 |
D/D |
(9,881) |
831,543 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-04-17 |
4 |
OE |
$34.86 |
$232,516 |
D/D |
6,670 |
841,424 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-07-10 |
4 |
S |
$36.93 |
$43,319 |
D/D |
(1,173) |
850,370 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-07-16 |
4 |
S |
$38.96 |
$48,739 |
D/D |
(1,251) |
849,119 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-09-01 |
4 |
AS |
$45.82 |
$1,732,454 |
D/D |
(37,810) |
851,309 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-09-01 |
4 |
OE |
$32.25 |
$1,290,000 |
D/D |
40,000 |
889,119 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-10-01 |
4 |
AS |
$43.70 |
$875,133 |
D/D |
(20,000) |
851,309 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-10-01 |
4 |
OE |
$32.25 |
$645,000 |
D/D |
20,000 |
871,309 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-10-12 |
4 |
OE |
$32.25 |
$645,000 |
D/D |
20,000 |
871,309 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-10-12 |
4 |
AS |
$44.91 |
$849,024 |
D/D |
(18,905) |
852,404 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-11-02 |
4 |
OE |
$32.25 |
$658,577 |
D/D |
20,421 |
872,825 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-11-02 |
4 |
AS |
$43.50 |
$893,888 |
D/D |
(20,400) |
852,425 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-11-05 |
4 |
OE |
$32.25 |
$631,423 |
D/D |
19,579 |
872,004 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-11-05 |
4 |
AS |
$44.91 |
$831,060 |
D/D |
(18,505) |
853,499 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-12-04 |
4 |
AS |
$45.24 |
$1,710,524 |
D/D |
(37,810) |
855,689 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-12-04 |
4 |
OE |
$32.25 |
$1,290,000 |
D/D |
40,000 |
893,499 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2010-01-04 |
4 |
OE |
$32.25 |
$1,290,000 |
D/D |
40,000 |
893,499 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2010-01-04 |
4 |
AS |
$48.22 |
$1,839,657 |
D/D |
(37,810) |
855,689 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2010-01-11 |
4 |
S |
$47.79 |
$263,896 |
D/D |
(5,522) |
850,167 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2010-01-19 |
4 |
S |
$47.22 |
$61,103 |
D/D |
(1,294) |
848,873 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2010-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
870,873 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2010-01-28 |
4 |
A |
$22.90 |
$24,045 |
D/D |
1,050 |
920,138 |
0 |
- |
|
283 Records found
|
|
Page 4 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
